Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+6.4%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$22.5B
AUM Growth
+$1.51B
(+7.2%)
Cap. Flow
+$525M
Cap. Flow
% of AUM
2.33%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,345
New
342
Increased
297
Reduced
263
Closed
321
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$454M |
| 2 |
Amazon
AMZN
|
$409M |
| 3 |
Micron Technology
MU
|
$206M |
| 4 |
Coca-Cola
KO
|
$167M |
| 5 |
Biogen
BIIB
|
$139M |
Top Sells
| 1 |
Salesforce
CRM
|
$449M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
$274M |
| 3 |
Uber
UBER
|
$264M |
| 4 |
IBM
IBM
|
$223M |
| 5 |
Nike
NKE
|
$186M |
Sector Composition
| 1 | Healthcare | 25.06% |
| 2 | Technology | 23% |
| 3 | Consumer Discretionary | 11.81% |
| 4 | Financials | 7.3% |
| 5 | Industrials | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MREO
351
Mereo BioPharma
MREO
$282M
| $17M | 0.07% |
10,610,000
+635,000
| +6% | +$1.02M |
|
352
Crocs
CROX
$4.72B
| $16.9M | 0.07% |
131,524
+131,424
| +131,424% | +$16.9M |
|
353
BGC Group
BGC
$4.71B
| $16.8M | 0.07% |
3,618,479
-135,721
| -4% | -$631K |
|
354
Oshkosh
OSK
$8.93B
| $16.8M | 0.07% |
148,916
+78,916
| +113% | +$8.89M |
|
|
COUP
355
DELISTED
Coupa Software Incorporated
COUP
| $16.6M | 0.07% |
+105,300
| New | +$16.6M |
|
356
Stem
STEM
$117M
| $16.6M | 0.07% |
+43,700
| New | +$16.6M |
|
357
Maravai LifeSciences
MRVI
$363M
| $16.4M | 0.07% |
390,900
+261,412
| +202% | +$11M |
|
358
HCI Group
HCI
$2.21B
| $16.3M | 0.07% |
195,300
-23,343
| -11% | -$1.95M |
|
359
Hasbro
HAS
$11.2B
| $16.2M | 0.06% |
+158,784
| New | +$16.2M |
|
360
Angi Inc
ANGI
$811M
| $16.1M | 0.06% |
175,301
-105,810
| -38% | -$9.74M |
|
361
Pinnacle West Capital
PNW
$10.6B
| $16.1M | 0.06% |
+228,500
| New | +$16.1M |
|
362
Occidental Petroleum
OXY
$45.2B
| $16.1M | 0.06% |
554,569
+506,801
| +1,061% | +$14.7M |
|
363
EQT Corp
EQT
$32.2B
| $16M | 0.06% |
735,475
-400,739
| -35% | -$8.74M |
|
364
Ingredion
INGR
$8.24B
| $15.9M | 0.06% |
+164,841
| New | +$15.9M |
|
365
Palomar
PLMR
$3.3B
| $15.9M | 0.06% |
+245,938
| New | +$15.9M |
|
|
AAC.U
366
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
| $15.9M | 0.06% |
1,600,000
| – | – |
|
367
Dover
DOV
$24.4B
| $15.9M | 0.06% |
+87,441
| New | +$15.9M |
|
368
Amneal Pharmaceuticals
AMRX
$3.02B
| $15.9M | 0.06% |
3,311,400
-433,600
| -12% | -$2.08M |
|
369
Sotera Health
SHC
$4.44B
| $15.8M | 0.06% |
+669,660
| New | +$15.8M |
|
|
INFN
370
DELISTED
Infinera Corporation Common Stock
INFN
| $15.7M | 0.06% |
+1,642,000
| New | +$15.7M |
|
371
STAG Industrial
STAG
$6.9B
| $15.6M | 0.06% |
+326,200
| New | +$15.6M |
|
372
GSK
GSK
$81.5B
| $15.5M | 0.06% |
+280,480
| New | +$15.5M |
|
373
Robert Half
RHI
$3.77B
| $15.4M | 0.06% |
137,864
+23,784
| +21% | +$2.65M |
|
374
Pliant Therapeutics
PLRX
$114M
| $15.3M | 0.06% |
+1,135,100
| New | +$15.3M |
|
375
Ascendis Pharma
ASND
$12.5B
| $15.1M | 0.06% |
112,200
+19,891
| +22% | +$2.68M |
|